These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29117540)

  • 1. A Weak Spot in Multiple Protozoan Parasites.
    Wong W
    Structure; 2017 Nov; 25(11):1641-1643. PubMed ID: 29117540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
    Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
    Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of aminoacyl-tRNA synthetases from eukaryotic parasites for drug development.
    Gill J; Sharma A
    J Biol Chem; 2023 Mar; 299(3):102860. PubMed ID: 36596362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
    Yogavel M; Bougdour A; Mishra S; Malhotra N; Chhibber-Goel J; Bellini V; Harlos K; Laleu B; Hakimi MA; Sharma A
    PLoS Pathog; 2023 Feb; 19(2):e1011124. PubMed ID: 36854028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.
    Jain V; Yogavel M; Oshima Y; Kikuchi H; Touquet B; Hakimi MA; Sharma A
    Structure; 2015 May; 23(5):819-829. PubMed ID: 25817387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects of halofuginone as an antiprotozoal drug scaffold.
    Gill J; Sharma A
    Drug Discov Today; 2022 Sep; 27(9):2586-2592. PubMed ID: 35636724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases.
    Khan S
    Malar J; 2016 Apr; 15():203. PubMed ID: 27068331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The most prominent modulated Annexins during parasitic infections.
    Rashidi S; Mansouri R; Ali-Hassanzadeh M; Muro A; Nguewa P; Manzano-Román R
    Acta Trop; 2023 Jul; 243():106942. PubMed ID: 37172709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in host-protozoan-parasite interactions.
    Brenier-Pinchart MP; Pelloux H; Derouich-Guergour D; Ambroise-Thomas P
    Trends Parasitol; 2001 Jun; 17(6):292-6. PubMed ID: 11378037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis.
    Herwaldt BL; Juranek DD
    Am J Trop Med Hyg; 1993 Mar; 48(3):313-23. PubMed ID: 8097080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccines for parasitic infections.
    Kalinna BH
    Immunol Cell Biol; 1997 Aug; 75(4):370-5. PubMed ID: 9315480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasites.
    Theel ES; Pritt BS
    Microbiol Spectr; 2016 Aug; 4(4):. PubMed ID: 27726821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing and human parasitic protozoan diseases.
    Andrews KT; Fisher G; Skinner-Adams TS
    Int J Parasitol Drugs Drug Resist; 2014 Aug; 4(2):95-111. PubMed ID: 25057459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of DNA replication proteins in parasitic protozoans: possible role of CDK-like kinases.
    Deshmukh AS; Agarwal M; Dhar SK
    Curr Genet; 2016 Aug; 62(3):481-6. PubMed ID: 26780367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactive Peptides against Human Apicomplexan Parasites.
    Rivera-Fernández N; Anacleto-Santos J; Casarrubias-Tabarez B; López-Pérez TJ; Rojas-Lemus M; López-Valdez N; Fortoul TI
    Antibiotics (Basel); 2022 Nov; 11(11):. PubMed ID: 36421302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.
    Saint-Léger A; Sinadinos C; Ribas de Pouplana L
    Bioengineered; 2016 Apr; 7(2):60-4. PubMed ID: 26963157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemokines and their receptors during protist parasite infections.
    Menzies FM; Macphail D; Henriquez FL
    Parasitology; 2016 Dec; 143(14):1890-1901. PubMed ID: 27707418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.